Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.42 |
| ▸ | CDC25B | P30305 | 7/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.42 |
| ▸ | CDC25A | P30304 | 3/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | GNRHR | P30968 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.39 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304588 | 0.81 | ACE (0.56) | PTPN1CDC25BPTPN2CDC25AACE | |
| SCHEMBL3331695 | 0.81 | ACE (0.56) | PTPN1CDC25BPTPN2CDC25AACE | |
| SCHEMBL26730167 | 0.79 | NPC1 (0.43) | NPC1 | |
| SCHEMBL21416498 | 0.79 | ITGA4 (0.44) | PTPN1ACEPPARAITGB3ITGA2B | |
| SCHEMBL3789613 | 0.78 | HDAC1 (0.49) | PTPN1CDC25BPTPN2CDC25AACE | |
| SCHEMBL3784417 | 0.78 | PPARA (0.52) | PTPN1CDC25BPTPN2CDC25AACE | |
| SCHEMBL3738997 | 0.76 | ALDH1A1 (0.39) | PTPN1CDC25BPTPN2CDC25AGNRHR | |
| SCHEMBL3732120 | 0.76 | ALDH1A1 (0.39) | PTPN1CDC25BPTPN2CDC25AGNRHR | |
| SCHEMBL3732124 | 0.76 | ALDH1A1 (0.39) | PTPN1CDC25BPTPN2CDC25AGNRHR | |
| SCHEMBL13735004 | 0.75 | ITGA4 (0.43) | PTPN1CDC25BPTPN2CDC25AACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348422-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | Technische Universität Berlin (DE) | 2023-11-02 | — | — | US | disclosed |
| EP-2210882-A1 | Synthesis of new protected azahistidine, their processes and their use in synthesises | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2010-07-28 | — | — | EP | disclosed |
| WO-2010081882-A2 | SYNTHESIS OF NEW PROTECTED AZAHISTIDINES, THEIR PROCESSES AND THEIR USE IN SYNTHESISES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348422-A1 | ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS | ALB, AAAS, INF2 | PTPN1 4801/4885CDC25B 3283/4885PTPN2 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.